In recent years, researchers in the United States and overseas have found striking disparities between income groups with respect to the level of cancer care they’re receiving. The poorer the patient, the less care they’ve gotten.earlier this year declaring that in spite of decades of significant investments in expanding healthcare coverage and improving its delivery, health outcome “inequities in the U.S.
Reinforcing these findings—and expanding beyond NSCLC to include renal cell carcinoma and melanoma—low income was one of several key factors associated with less use of immunotherapy, according to a. The large-scale cohort study examined more than 400,000 patients. Researchers found significantly less frequent immunotherapy use among lower household income individuals, before and after new immunotherapeutic drugs called checkpoint inhibitors were approved by the Food and Drug Administration.
Similarly large differences were found with respect to treatment of metastatic colorectal cancer. To slow down the disease, patients can receive chemotherapy, possibly in combination with a targeted drug. In the higher income group, 54% received this dual treatment while in the lower income group only 39% did.
Interestingly, patients with advanced cancer from lower income groups visit a care provider more often in the last six months before their death than patients in higher income brackets.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: PhillyDailyNews - 🏆 89. / 67 Read more »
Source: aldotcom - 🏆 82. / 68 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: bbchealth - 🏆 143. / 63 Read more »
Source: Health - 🏆 396. / 53 Read more »